Kenneth C. Anderson (physician)

Kenneth C. Anderson, M.D., is a hematologist-oncologist specializing in the research and treatment of multiple myeloma. He is primarily known for his extensive contributions to understanding the pathogenesis of multiple myeloma, and for the development of novel therapies that have significantly improved patient outcomes.

Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School and the Program Director of the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. His research focuses on the tumor microenvironment in multiple myeloma, mechanisms of drug resistance, and the development of targeted therapies, including immunotherapies and proteasome inhibitors.

He has authored or co-authored hundreds of peer-reviewed publications and has received numerous awards for his contributions to cancer research. His work has been instrumental in the approval of several new therapies for multiple myeloma. His dedication to research and patient care has made him a leading figure in the field of hematologic malignancies.